MedTrace Logo

Cold Plasma for Wound Treatment, Safety Study

NCT03007264 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2018-08-20

No results posted yet for this study

Summary

In this study the application of cold atmospheric plasma (CAP) will be tested on intact skin of volunteers. To test safety, several skin parameters will be monitored, the antimicrobial effect will be investigated as well. The investigators expect this treatment to have a good antimicrobial effect with acceptable, transient skin sensations.

Conditions

  • Intact Skin
  • Contaminant Given to Patient

Interventions

DEVICE

Cold Atmospheric Plasma

CAP will be applied on one volar arm of volunteers for a total of 2 minutes.

Sponsors & Collaborators

  • Eindhoven University of Technology

    collaborator OTHER

  • Association of Dutch Burn Centres

    lead OTHER

Principal Investigators

  • Esther Middelkoop, PhD · Red Cross Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-06-18
Primary Completion
2018-07-12
Completion
2018-07-26

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03007264 on ClinicalTrials.gov